NCT02446769View on ClinicalTrials.gov

A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD

NATerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 6, 2017

Primary Completion Date

May 3, 2018

Study Completion Date

May 21, 2018

Conditions
Breathing-Related Sleep Disorder
Interventions
DEVICE

AVAPS-AE Non-invasive ventilation therapy

Participants will use the device greater than or equal to 4hrs per night for the 60 days after discharge.

Trial Locations (1)

85724

University of Arizona, Tucson

Sponsors
All Listed Sponsors
collaborator

University of Arizona

OTHER

lead

Philips Respironics

INDUSTRY